Isofol Medical AB (OSTO:ISOFOL) Total Liabilities : kr19.09 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Isofol Medical AB Total Liabilities?

Isofol Medical AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr19.09 Mil.

Isofol Medical AB's quarterly Total Liabilities declined from Sep. 2023 (kr19.82 Mil) to Dec. 2023 (kr19.17 Mil) and declined from Dec. 2023 (kr19.17 Mil) to Mar. 2024 (kr19.09 Mil).

Isofol Medical AB's annual Total Liabilities declined from Dec. 2021 (kr83.13 Mil) to Dec. 2022 (kr51.39 Mil) and declined from Dec. 2022 (kr51.39 Mil) to Dec. 2023 (kr19.17 Mil).

Isofol Medical AB Total Liabilities Historical Data

The historical data trend for Isofol Medical AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB Total Liabilities Chart

Isofol Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

41.56

81.56

83.13

51.39

19.17

Isofol Medical AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															28.01	25.26	19.82	19.17	19.09

Isofol Medical AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Isofol Medical AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18.253	+	(0	+	0.912
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	19.17

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	140.597	-	121.432
	=	19.17

Isofol Medical AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18.45	+	(0	+	0.64
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	19.09

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	132.041	-	112.951
	=	19.09

Isofol Medical AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Isofol Medical AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Isofol Medical AB (OSTO:ISOFOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (OSTO:ISOFOL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

5IU:Germany

Address

Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46

Website

http://www.isofol.se

Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB (OSTO:ISOFOL) Headlines

No Headlines